PMID- 30201381 OWN - NLM STAT- MEDLINE DCOM- 20190827 LR - 20190827 IS - 1874-1754 (Electronic) IS - 0167-5273 (Linking) VI - 276 DP - 2019 Feb 1 TI - Mode of death and predictors of mortality in adult Fontan survivors: A Japanese multicenter observational study. PG - 74-80 LID - S0167-5273(18)34483-8 [pii] LID - 10.1016/j.ijcard.2018.09.002 [doi] AB - BACKGROUND: Mortality rates may be high in adult Fontan patients; however, the clinical determinants remain unclear. PURPOSE: We conducted a prospective multicenter study of adult Fontan survivors to determine the 5-year mortality rate and clarify the determinants. METHOD AND RESULTS: We followed 600 adult Fontan survivors from 40 Japanese institutions (307 men, 28 +/- 7 years old, follow-up: 18 +/- 6 years). The New York Heart Association (NYHA) functional class I and II was 51% and 42%, respectively. During the follow-up period of 4.1 +/- 1.6 years, 33 patients died, and the 5-year survival rate was 93.5%. The mode of death was heart failure in 11 patients (34%), arrhythmia or sudden death in 8 (24%), cancer in 5 (15%), perioperative problems and hemostatic problems in 4 each (12% for each), and infection in 1 (3%). Left isomerism, prior hospitalization, protein losing enteropathy (PLE), pulmonary arteriovenous fistulae, NYHA functional class, impaired hemodynamics, hyponatremia, hepatorenal dysfunction, and use of diuretics were associated with a high mortality rate (p < 0.05-0.0001). Further, PLE (hazard ratio [HR]: 14.4), left isomerism (HR: 3.5), and NYHA (HR: 2.4) independently predicted a high 5-year high mortality (p < 0.05 for all). The incidence of cancer-related mortality increased markedly with age >40 years. CONCLUSIONS: Majority of the Japanese adult Fontan survivors had good functional status, with an acceptable 5-year survival rate. However, the significant prevalence of non-cardiac mortality highlights Fontan pathophysiology as a multi-organ disease that requires a multidisciplinary management strategy to improve the long-term outcome. CI - Copyright (c) 2018. Published by Elsevier B.V. FAU - Ohuchi, Hideo AU - Ohuchi H AD - Department of Pediatric Cardiology and Adult Congenital Heart Disease, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan. Electronic address: hohuchi@ncvc.go.jp. FAU - Inai, Kei AU - Inai K AD - Pediatric Cardiology, Tokyo Women's Medical University, Shinjuku, Tokyo, Japan. FAU - Nakamura, Makoto AU - Nakamura M AD - Cardiology, Fukuoka Children's Hospital, Fukuoka, Fukuoka, Japan. FAU - Park, In-Sam AU - Park IS AD - Pediatric Cardiology, Sakakibara Heart Institution, Fuchu, Tokyo, Japan. FAU - Watanabe, Mamie AU - Watanabe M AD - Pediatric Cardiology, Kyushu Hospital (JCHO), Kitakyushu, Fukuoka, Japan. FAU - Hiroshi, Ono AU - Hiroshi O AD - Cardiology, National Center for Child Health and Development, Setagaya-ku, Tokyo, Japan. FAU - Kim, Ki-Sung AU - Kim KS AD - Cardiology, Kanagawa Children's Medical Center, Yokohama, Kanagawa, Japan. FAU - Sakazaki, Hisanori AU - Sakazaki H AD - Pediatric Cardiology, Hyogo Prefectural Amagasaki General Medical Center, Amagasaki, Hyogo, Japan. FAU - Waki, Kenji AU - Waki K AD - Pediatric Cardiology, Kurashiki Central Hospital, Kurashiki, Okayama, Japan. FAU - Yamagishi, Hiroyuki AU - Yamagishi H AD - Pediatrics, Keio University School of Medicine, Shinjuku-ku, Tokyo, Japan. FAU - Yamamura, Kenichiro AU - Yamamura K AD - Pediatrics, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Fukuoka, Japan. FAU - Kuraishi, Kenji AU - Kuraishi K AD - Pediatric Cardiology and Neonatology, Ogaki Municipal Hospital, Ogaki, Gifu, Japan. FAU - Miura, Masaru AU - Miura M AD - Cardiology, Tokyo Metropolitan Children's Medical Center, Fuchu, Tokyo, Japan. FAU - Nakai, Michikazu AU - Nakai M AD - Preventive Medicine and Epidemiologic Informatics, Center for Cerebral and Cardiovascular Center, Japan. FAU - Nishimura, Kunihiro AU - Nishimura K AD - Preventive Medicine and Epidemiologic Informatics, Center for Cerebral and Cardiovascular Center, Japan. FAU - Niwa, Koichiro AU - Niwa K AD - Cardiology, St Luke's International Hospital, Chuo-ku, Tokyo, Japan. CN - JSACHD Fontan Investigators LA - eng PT - Journal Article PT - Multicenter Study PT - Observational Study DEP - 20180905 PL - Netherlands TA - Int J Cardiol JT - International journal of cardiology JID - 8200291 SB - IM CIN - Int J Cardiol. 2019 Feb 1;276:110-111. PMID: 30340849 MH - Adolescent MH - Adult MH - Cause of Death/*trends MH - Female MH - Follow-Up Studies MH - Fontan Procedure/*mortality/*trends MH - Heart Diseases/diagnosis/*mortality MH - Humans MH - Japan/epidemiology MH - Male MH - Middle Aged MH - Neoplasms/diagnosis/*mortality MH - Predictive Value of Tests MH - Prospective Studies MH - Survival Rate/trends MH - Young Adult OTO - NOTNLM OT - Adult Fontan OT - Arrhythmia OT - Cancer OT - Heart failure OT - Mortality EDAT- 2018/09/12 06:00 MHDA- 2019/08/28 06:00 CRDT- 2018/09/12 06:00 PHST- 2018/07/16 00:00 [received] PHST- 2018/08/28 00:00 [revised] PHST- 2018/09/03 00:00 [accepted] PHST- 2018/09/12 06:00 [pubmed] PHST- 2019/08/28 06:00 [medline] PHST- 2018/09/12 06:00 [entrez] AID - S0167-5273(18)34483-8 [pii] AID - 10.1016/j.ijcard.2018.09.002 [doi] PST - ppublish SO - Int J Cardiol. 2019 Feb 1;276:74-80. doi: 10.1016/j.ijcard.2018.09.002. Epub 2018 Sep 5.